Rahul Khurana: Intravitreal Injections a Difficult Treatment Choice but Often Better Than Blindness

Video

The discussion of intravitreal injections may not be an easy one for doctors to have with their patients, but when the full treatment picture is explained it can show how the benefits outweigh other potential issues.

The discussion of intravitreal injections may not be an easy one for doctors to have with their patients, but when the full treatment picture is explained it can show how the benefits outweigh other potential issues.

Rahul N. Khurana, MD, from Northern California Retina Vitreous Associates, said that while diagnosing conditions like central retinal vein occlosion can be done by most eyecare professionals the treatment, especially when it comes to injections, should only be done by specialists with experience in the field. Khurana also said that communication from diagnosis through treatment can often make a big difference in how receptive a patient is to the process as a whole.

Related Videos
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Dolly Chang, MD, PhD | Image Credit: LinkedIn
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
© 2024 MJH Life Sciences

All rights reserved.